☰

Qinqin Cheng - Publications

Affiliations: 
University of Southern California, Los Angeles, CA, United States 
Tree Info Similar researchers PubMed Report error

23 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Cheng Q, Zhang XN, Li J, Chen J, Wang Y, Zhang Y. Synthesis of Bispecific Antibody Conjugates Using Functionalized Poly-ADP-ribose Polymers. Biochemistry. PMID 36821831 DOI: 10.1021/acs.biochem.2c00718  0.707
2022 Cheng Q, Zhang XN, Zhang L, Chen J, Wang Y, Zhang Y. A Poly-ADP-Ribose Polymer-GCSF Conjugate. Biomacromolecules. PMID 36350184 DOI: 10.1021/acs.biomac.2c01090  0.664
2022 Cheng Q, Dai Z, Smbatyan G, Epstein AL, Lenz HJ, Zhang Y. Eliciting Anti-Cancer Immunity by Genetically Engineered Multifunctional Exosomes. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 35746867 DOI: 10.1016/j.ymthe.2022.06.013  0.622
2022 Zhang XN, Lam AT, Cheng Q, Courouble VV, Strutzenberg TS, Li J, Wang Y, Pei H, Stiles BL, Louie SG, Griffin PR, Zhang Y. Discovery of an NAD analogue with enhanced specificity for PARP1. Chemical Science. 13: 1982-1991. PMID 35308855 DOI: 10.1039/d1sc06256e  0.748
2021 Cheng Q, Dai Z, Shi X, Duan X, Wang Y, Hou T, Zhang Y. Expanding the toolbox of exosome-based modulators of cell functions. Biomaterials. 277: 121129. PMID 34534861 DOI: 10.1016/j.biomaterials.2021.121129  0.695
2021 Dai Z, Zhang XN, Cheng Q, Fei F, Hou T, Li J, Abdolvahabi A, Watanabe J, Pei H, Smbatyan G, Xie J, Lenz HJ, Louie SG, Zhang Y. Site-specific antibody-drug conjugates with variable drug-to-antibody-ratios for AML therapy. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 34197861 DOI: 10.1016/j.jconrel.2021.06.041  0.714
2020 Shi X, Zhang XN, Chen J, Cheng Q, Pei H, Louie SG, Zhang Y. A poly-ADP-ribose polymer-based antibody-drug conjugate. Chemical Science. 11: 9303-9308. PMID 33623656 DOI: 10.1039/D0Sc01795G  0.754
2020 Dai Z, Zhang XN, Nasertorabi F, Cheng Q, Li J, Katz BB, Smbatyan G, Pei H, Louie SG, Lenz HJ, Stevens RC, Zhang Y. Synthesis of site-specific antibody-drug conjugates by ADP-ribosyl cyclases. Science Advances. 6: eaba6752. PMID 32537509 DOI: 10.1126/Sciadv.Aba6752  0.744
2020 Dai Z, Cheng Q, Zhang Y. Rational Design of a Humanized Antibody Inhibitor of Cathepsin B. Biochemistry. PMID 32212642 DOI: 10.1021/Acs.Biochem.0C00046  0.621
2020 Cheng Q, Shi X, Zhang Y. Reprogramming Exosomes for Immunotherapy. Methods in Molecular Biology (Clifton, N.J.). 2097: 197-209. PMID 31776927 DOI: 10.1007/978-1-0716-0203-4_12  0.653
2019 Shi X, Cheng Q, Hou T, Han M, Smbatyan G, Lang JE, Epstein AL, Lenz HJ, Zhang Y. Genetically Engineered Cell-Derived Nanoparticles for Targeted Breast Cancer Immunotherapy. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 31843452 DOI: 10.1016/J.Ymthe.2019.11.020  0.751
2019 Shi X, Cheng Q, Zhang Y. Reprogramming Extracellular Vesicles with Engineered Proteins. Methods (San Diego, Calif.). PMID 31568822 DOI: 10.1016/J.Ymeth.2019.09.017  0.578
2019 Zhang XN, Cheng Q, Chen J, Lam AT, Lu Y, Dai Z, Pei H, Evdokimov NM, Louie SG, Zhang Y. A ribose-functionalized NAD with unexpected high activity and selectivity for protein poly-ADP-ribosylation. Nature Communications. 10: 4196. PMID 31519936 DOI: 10.1038/S41467-019-12215-4  0.724
2019 Zhang XN, Dai Z, Cheng Q, Zhang Y. Chemoenzymatic Preparation of 4'-Thioribose NAD. Current Protocols in Nucleic Acid Chemistry. e83. PMID 30951610 DOI: 10.1002/Cpnc.83  0.676
2018 Dai Z, Zhang XN, Nasertorabi F, Cheng Q, Pei H, Louie SG, Stevens RC, Zhang Y. Facile chemoenzymatic synthesis of a novel stable mimic of NAD. Chemical Science. 9: 8337-8342. PMID 30568770 DOI: 10.1039/c8sc03899f  0.702
2018 Cheng Q, Shi X, Han M, Smbatyan G, Lenz HJ, Zhang Y. Reprogramming Exosomes as Nanoscale Controllers of Cellular Immunity. Journal of the American Chemical Society. PMID 30452238 DOI: 10.1021/Jacs.8B10047  0.75
2016 Cheng Q, Shi H, Wang H, Wang J, Liu Y. Asplatin enhances drug efficacy by altering the cellular response. Metallomics : Integrated Biometal Science. PMID 27125788 DOI: 10.1039/C6Mt00066E  0.356
2016 Cheng Q, Liu Y. Multifunctional platinum-based nanoparticles for biomedical applications. Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology. PMID 27094725 DOI: 10.1002/Wnan.1410  0.324
2016 Cao ZT, Chen ZY, Sun CY, Li HJ, Wang HX, Cheng QQ, Zuo ZQ, Wang JL, Liu YZ, Wang YC, Wang J. Overcoming tumor resistance to cisplatin by cationic lipid-assisted prodrug nanoparticles. Biomaterials. 94: 9-19. PMID 27088406 DOI: 10.1016/J.Biomaterials.2016.04.001  0.315
2015 Shi H, Cheng Q, Yuan S, Ding X, Liu Y. Human Serum Albumin Conjugated Nanoparticles for pH and Redox-Responsive Delivery of a Prodrug of Cisplatin. Chemistry (Weinheim An Der Bergstrasse, Germany). PMID 26405808 DOI: 10.1002/Chem.201502756  0.355
2014 Cheng Q, Shi H, Wang H, Min Y, Wang J, Liu Y. The ligation of aspirin to cisplatin demonstrates significant synergistic effects on tumor cells. Chemical Communications (Cambridge, England). 50: 7427-30. PMID 24777030 DOI: 10.1039/C4Cc00419A  0.327
2014 Zhao L, Cheng Q, Wang Z, Xi Z, Xu D, Liu Y. Cisplatin binds to human copper chaperone Cox17: the mechanistic implication of drug delivery to mitochondria. Chemical Communications (Cambridge, England). 50: 2667-9. PMID 24473407 DOI: 10.1039/C3Cc48847K  0.323
2013 Xu D, Min Y, Cheng Q, Shi H, Wei K, Arnesano F, Natile G, Liu Y. Chemical and cellular investigations of trans-ammine-pyridine-dichlorido-platinum(II), the likely metabolite of the antitumor active cis-diammine-pyridine-chorido-platinum(II). Journal of Inorganic Biochemistry. 129: 15-22. PMID 24008133 DOI: 10.1016/J.Jinorgbio.2013.07.040  0.311
Show low-probability matches.